Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             20 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abramson JS, Siddiqi T, Garcia J, et al. Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial. Blood Adv. 2021;5(6):1695-1705.
6 22 p. 5885
artikel
2 Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr Palumbo, Joseph S.

6 22 p. 5821-5828
artikel
3 CD58 loss in tumor cells confers functional impairment of CAR T cells Yan, Xin

6 22 p. 5844-5856
artikel
4 Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level Schinke, Carolina

6 22 p. 5873-5883
artikel
5 Chari A, Cho HJ, Dhadwal A, et al. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv. 2017;1(19):1575-1583.
6 22 p. 5884
artikel
6 Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia Brandão, Leonardo R.

6 22 p. 5908-5923
artikel
7 Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation Nawas, Mariam T.

6 22 p. 5898-5907
artikel
8 Editorial Board
6 22 p. i
artikel
9 Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma Salles, Gilles

6 22 p. 5835-5843
artikel
10 Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies Fathi, Amir T.

6 22 p. 5857-5865
artikel
11 Front Matter
6 22 p. ii
artikel
12 Introduction of an ancient founder glycoprotein VI mutation into the Chilean population Dalby, Amanda

6 22 p. 5866-5869
artikel
13 Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene Kuijpers, Taco W.

6 22 p. 5829-5834
artikel
14 More to voxelotor than meets the eye? Bovino, Robert C.

6 22 p. 5870-5872
artikel
15 Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency Seanoon, Karnsasin

6 22 p. 5887-5897
artikel
16 Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML Pianigiani, Giulia

6 22 p. 5938-5949
artikel
17 Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma Ferreri, Andrés J. M.

6 22 p. 5811-5820
artikel
18 Smith CC, Levis MJ, Perl AE, et al. Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood Adv. 2022;6(7):2144-2155.
6 22 p. 5886
artikel
19 Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate Tang, Thao

6 22 p. 5933-5937
artikel
20 The outcome of older adults with classic Hodgkin lymphoma in British Columbia Cheng, Phoebe T. M.

6 22 p. 5924-5932
artikel
                             20 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland